• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Champions Oncology, Inc. - Common Stock (NQ:CSBR)

    4.970 UNCHANGED
    Streaming Delayed Price Updated: 2:31 PM EDT, Aug 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 4.970
    Bid (Size) 4.870 (600)
    Ask (Size) 7.770 (100)
    Prev. Close 4.970
    Today's Range 4.970 - 4.970
    52wk Range 4.830 - 8.740
    Shares Outstanding 13,415,066
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Champions Oncology Q4 Earnings Call Highlights ↗
    Champions Oncology (NASDAQ:CSBR) reported record revenue for fiscal 2026 and positive adjusted EBITDA in every quarter of the year, supported by growth in its core Translational Oncology Solutions, or... 
    Via MarketBeat
    Topics Earnings
    Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock ↗
    Via Chartmill
    Topics Earnings

    Performance

    YTD
    -25.4%
    -25.4%
    1 Month
    -18.0%
    -18.0%
    3 Month
    -17.0%
    -17.0%
    6 Month
    -15.0%
    -15.0%
    1 Year
    -29.6%
    -29.6%

    More News

    Read More
    News headline image
    Champions Oncology Reports Record Annual Revenue of $59 Million
    From Champions Oncology, Inc.
    Via ACCESS Newswire
    News headline image
    Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
    From Champions Oncology, Inc.
    Via ACCESS Newswire
    News headline image
    Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
    Via ACCESS Newswire
    Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
    Via Chartmill
    News headline image
    Insights Ahead: Champions Oncology's Quarterly Earnings ↗
    Via Benzinga
    News headline image
    Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
    Via ACCESS Newswire
    News headline image
    Champions Oncology (CSBR) Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Champions Oncology Reports Revenue of $16.6 Million
    Via ACCESS Newswire
    News headline image
    Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
    Via ACCESS Newswire
    News headline image
    Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Champions Oncology (CSBR) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Champions Oncology (CSBR) Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
    Via Chartmill
    News headline image
    Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
    Via ACCESS Newswire
    News headline image
    CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    News headline image
    Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
    Via Chartmill
    News headline image
    Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For September 15, 2025 ↗
    Via Benzinga
    News headline image
    Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
    Via ACCESS Newswire
    News headline image
    4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗
    Via Benzinga

    Frequently Asked Questions

    Is Champions Oncology, Inc. - Common Stock publicly traded?
    Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
    What exchange does Champions Oncology, Inc. - Common Stock trade on?
    Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
    The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
    What is the current price of Champions Oncology, Inc. - Common Stock?
    The current price of Champions Oncology, Inc. - Common Stock is 4.970
    When was Champions Oncology, Inc. - Common Stock last traded?
    The last trade of Champions Oncology, Inc. - Common Stock was at 08/24/26 02:31 PM ET
    What is the market capitalization of Champions Oncology, Inc. - Common Stock?
    The market capitalization of Champions Oncology, Inc. - Common Stock is 66.67M
    How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
    Champions Oncology, Inc. - Common Stock has 67M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.